Provigil (Modafinil) Study by Taiwan Biotech Co.

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Sep 14, 2005

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Polysomnographic findings of shortened sleep latency less than 5 minutes average of Multiple Sleep Latency Test, and two or more SOREM should be fulfilled.
• • Age of 12 y/o to 55 y/o.
• • The liver and kidney functions are within normal limits.
• • Meeting the strict criteria of narcolepsy described above.
• • Wash out any medications which might enhance wakefulness or affect nocturnal sleep two weeks prior to the experiments.
• • Willingness to comply with the protocol and signed the written Informed Consent.
• Exclusion Criteria:
• • Patients whose hypersomnia was caused by severely sleep deprived, phase delayed, or suspected long sleeper.
• • Patients with concomitant neurological disorder and psychiatric disorders.
• • Patients with sleep-related breathing disorders whose apnea/hypopnea index (AHI) was 5 pauses per hour above.
• • Patients with Restless Leg Syndrome \& Periodic Limbs Movements whose index was more than 5 per hour.
• • Patients who are pregnant or breast-feeding.